Immunoinformatics comes of age

PLoS Computational Biology

Volumn 2, Issue 6, 2006, Pages 0484-0492

  Korber, Bette ^a,b   LaBute, Montiago ^a   Yusim, Karina ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b SANTA FE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS; EPITOPES; IMMUNE SYSTEM; T-CELLS;

ADAPTIVE IMMUNE RESPONSE; ANALYSIS TOOLS; B CELL EPITOPES PREDICTIONS; DESIGN STRUCTURE; IMMUNE RESPONSE; INTERNET RESOURCES; PROTEIN STRUCTURE COMPARISON; SCIENTIFIC LITERATURE; SEARCHABLE DATABASE; WEB INTERFACE;

VACCINES;

CYTOKINE; EPITOPE; HLA ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER PROGRAM; CRYSTAL STRUCTURE; DATA BASE; GENOTYPE; IMMUNE RESPONSE; INFORMATION SCIENCE; INTERNET; MATHEMATICAL COMPUTING; PROTEIN STRUCTURE; PUBLIC HEALTH SERVICE; REVIEW; T LYMPHOCYTE; ANIMAL; BIOLOGY; CHEMISTRY; FACTUAL DATABASE; HUMAN; IMMUNITY; IMMUNOLOGY;

AMINO ACID SEQUENCE; ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNITY;

EID: 33745608737     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0020071     Document Type: Review

References (97)

1. Eckmann L (2006) Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 22: 95-101.
2. Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, et al. (2001) Crystal structure of a neutralizing human IGG against HIV-1: A template for vaccine design. Science 293: 1155-1159.
3. Hanada K, Yewdell JW, Yang JC (2004) Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427: 252-256.
4. Janeway CA, Travers P, Walport M, Shlomchik M (2005) Immunobiology. New York: Garland Science Publishing. 600 p.
5. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419-466.
6. Maenaka K, Jones EY (1999) MHC superfamily structure and the immune system. Curr Opin Struct Biol 9: 745-753.
7. Messaoudi I, LeMaoult J, Metzner BM, Miley MJ, Fremont DH, et al. (2001) Functional evidence that conserved TCR CDR alpha 3 loop docking governs the cross-recognition of closely related peptide:class I complexes. J Immunol 167: 836-843.
8. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, et al. (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
9. + T cells. J Exp Med 199: 925-936.
10. Hammond SA, Obah E, Stanhope P, Monell CR, Strand M, et al. (1991) Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. J Immunol 146: 1470-1477.
11. Matsumura M, Fremont DH, Peterson PA, Wilson IA (1992) Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257: 927-934.
12. Pamer E, Cresswell P (1998) Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16: 323-358.
13. Craiu A, Akopian T, Goldberg A, Rock KL (1997) Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A 94: 10850-10855.
14. Mo XY, Cascio P, Lemerise K, Goldberg AL, Rock K (1999) Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J Immunol 163: 5851-5859.
15. Abele R, Tampe R (1999) Function of the transport complex TAP in cellular immune recognition. Biochim Biophys Acta 1461: 405-419.
16. + CTL. J Immunol 154: 6140-6156.
17. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, et al. (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78: 7069-7078.
18. Niedermann G, Geier E, Lucchiari-Hartz M, Hitziger N, Ramsperger A, et al. (1999) The specificity of proteasomes: Impact on MHC class I processing and presentation of antigens. Immunol Rev 172: 29-48.
19. Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, et al. (1998) Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol 161: 617-624.
20. Brusic V, Rudy G, Harrison LC (1998) MHCPEP, a database of MHC-binding peptides: Update 1997. Nucleic Acids Res 26: 368-371.
21. Bhasin M, Singh H, Raghava GP (2003) MHCBN: A comprehensive database of MHC binding and non-binding peptides. Bioinformatics 19: 665-666.
22. Peters B, Sidney J, Bourne P, Bui HH, Buus S, et al. (2005) The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol 3: e91. DOI: 10.1371/journal.pbio.0030091
23. Marsh SGE, Parjam P, Barber LD (2000) The HLA factsbook. London: Academic Press. 416 p.
24. Rammensee HG, Bachman J, Stevanovich S (1997) MHC ligands and peptide motifs. Georgetown: Landes Bioscience. pp. 1-462.
25. Sette A, Buus S, Appella E, Smith JA, Chesnut R, et al. (1989) Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A 86: 3296-3300.
26. Nijman HW, Houbiers JG, Vierboom MP, van der Burg SH, Drijfhout JW, et al. (1993) Identification of peptide sequences that potentially trigger HLAA2.1-restricted cytotoxic T lymphocytes. Eur J Immunol 23: 1215-1219.
27. Buus S (1999) Description and prediction of peptide-MHC binding: The "human MHC project." Curr Opin Immunol 11: 209-213.
28. De Groot AS, Bosma A, Chinai N, Frost J, Jesdale BM, et al. (2001) From genome to vaccine: In silico predictions, ex vivo verification. Vaccine 19: 4385-4395.
29. De Groot AS, Marcon L, Bishop EA, Rivera D, Kutzler M, et al. (2005) HIV vaccine development by computer assisted design: The GAIA vaccine. Vaccine 23: 2136-2148.
30. Lauemoller SL, Holm A, Hilden J, Brunak S, Holst Nissen M, et al. (2001) Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations. Tissue Antigens 57: 405-414.
31. Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163-175.
32. Brusic V, Bajic VB, Petrovsky N (2004) Computational methods for prediction of T-cell epitopes - A framework for modelling, testing, and applications. Methods 34: 436-443.
33. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
34. Thakalapally R, Kibbe W, Lang D, Korber B, Korber B, et al. (2000) Motifscan: A Web-based tool to find HLA anchor residues in proteins or peptides. HIV Molecular Immunology Database 2000. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. Publication number LA-UR 02-2877. pp. I-101.
35. Yusim KSJ,, Honeyborne I, Calef C, Goulder PJ, Korber BT (2004) Enhanced motif scan: A tool to scan for HLA anchor residues in proteins. HIV Immunology and HIV/SIV Vaccine Databases 2003. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. Publication number LA-UR 04-8162. pp. 25-36.
36. Calef C, Thakalapally R, Kaslow R, Mulligan M, Korber B, et al. (2001) ELF: An analysis tool for HIV-1 peptides and HLA types. HIV Molecular Immunology 2001. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. Publication number LA-UR 02-2877. pp. I-21.
37. Korber BT, Brander C, Haynes B, Koup R, Moore JP, et al. (2005) HIV molecular immunology 2005. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. Publication number LA-UR 06-0036. pp. 1-1158. Available: http://www.hiv.lanl.gov/content/immunology/index.html. Accessed 4 June 2006.
38. Yusim K, Richardson R, Tao N, Dalwani A, Agrawal A, et al. (2005) Los Alamos hepatitis C immunology database. Appl Bioinformatics 4: 217-225.
39. Leggatt GR, Hosmalin A, Pendleton CD, Kumar A, Hoffman S, et al. (1998) The importance of pairwise interactions between peptide residues in the delineation of TCR specificity. J Immunol 161: 4728-4735.
40. Bhasin M, Raghava GP (2004) Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22: 3195-3204.
41. Bhasin M, Raghava GP (2004) Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci 13: 596-607.
42. Bhasin M, Raghava GP (2005) Pcleavage: An SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res 33: W202-W207.
43. Gulukota K, Sidney J, Sette A, DeLisi C (1997) Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol 267: 1258-1267.
44. Kesmir C, Nussbaum AK, Schild H, Detours V, Brunak S (2002) Prediction of proteasome cleavage motifs by neural networks. Protein Eng 15: 287-296.
45. Kuttler C, Nussbaum AK, Dick TP, Rammensee HG, Schild H, et al. (2000) An algorithm for the prediction of proteasomal cleavages. J Mol Biol 298: 417-429.
46. Milik M, Sauer D, Brunmark AP, Yuan L, Vitiello A, et al. (1998) Application of an artificial neural network to predict specific class I MHC binding peptide sequences. Nat Biotechnol 16: 753-756.
47. Schonbach C, Kun Y, Brusic V (2002) Large-scale computational identification of HIV T-cell epitopes. Immunol Cell Biol 80: 300-306.
48. Yu K, Petrovsky N, Schonbach C, Koh JY, Brusic V (2002) Methods for prediction of peptide binding to MHC molecules: A comparative study. Mol Med 8: 137-148.
49. Lund O, Nielsen M, Kesmir C, Christensen JK, Lundegaard C, et al. (2002) Web-based tools for vaccine design. In: Korber BT, Brander C, Haynes BF, Koup R, Kuiken C, et al., editors. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. pp. 48-55 Available: http://www.hiv.lanl. gov/content/hiv-db/REVIEWS/Lund2002.html.Accessed 4 June 2006.
50. Guan P, Doytchinova IA, Zygouri C, Flower DR (2003) MHCPred: Bringing a quantitative dimension to the online prediction of MHC binding. Appl Bioinformatics 2: 63-66.
51. Guan P, Doytchinova IA, Zygouri C, Flower DR (2003) MHCPred: A server for quantitative prediction of peptide-MHC binding. Nucleic Acids Res 31: 3621-3624.
52. Altuvia Y, Sette A, Sidney J, Southwood S, Margalit H (1997) A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets. Hum Immunol 58: 1-11.
53. Schueler-Furman O, Altuvia Y, Sette A, Margalit H (2000) Structure-based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles. Protein Sci 9: 1838-1846.
54. Altuvia Y, Margalit H (2000) Sequence signals for generation of antigenic peptides by the proteasome: Implications for proteasomal cleavage mechanism. J Mol Biol 295: 879-890.
55. Parker KC, Shields M, DiBrino M, Brooks A, Coligan JE (1995) Peptide binding to MHC class I molecules: Implications for antigenic peptide prediction. Immunol Res 14: 34-57.
56. Hakenberg J, Nussbaum AK, Schild H, Rammensee HG, Kuttler C, et al. (2003) MAPPP: MHC class I antigenic peptide processing prediction. Appl Bioinformatics 2: 155-158.
57. Holzhutter HG, Frommel C, Kloetzel PM (1999) A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. J Mol Biol 286: 1251-1265.
58. Holzhutter HG, Kloetzel PM (2000) A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. Biophys J 79: 1196-1205.
59. Nielsen M, Lundegaard C, Lund O, Kesmir C (2005) The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57: 33-41.
60. Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, et al. (2003) Sensitive quantitative predictions of peptide-MHC binding by a "Query by Committee" artificial neural network approach. Tissue Antigens 62: 378-384.
61. Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, et al. (2004) Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 20: 1388-1397.
62. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12: 1007-1017.
63. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55: 797-810.
64. Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50: 201-212.
65. Peters B, Bulik S, Tampe R, Van Endert PM, Holzhutter HG (2003) Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol 171: 1741-1749.
66. Saha S, Bhasin M, Raghava GP (2005) Bcipep: A database of B-cell epitopes. BMC Genomics 6: 79.
67. Singh H, Raghava GP (2001) ProPred: Prediction of HLA-DR binding sites. Bioinformatics 17: 1236-1237.
68. Singh H, Raghava GP (2003) ProPred1: Prediction of promiscuous MHC class-I binding sites. Bioinformatics 19: 1009-1014.
69. Bhasin M, Raghava GP (2003) Prediction of promiscuous and high-affinity mutated MHC binders. Hybrid Hybridomics 22: 229-234.
70. Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A, et al. (2005) Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57: 304-314.
71. Peters B, Sette A (2005) Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6: 132.
72. Tenzer S, Peters B, Bulik S, Schoor O, Lemmel C, et al. (2005) Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci 62: 1025-1037.
73. De Groot AS, Jesdale B, Martin W, Saint Aubin C, Sbai H, et al. (2003) Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. Vaccine 21: 4486-4504.
74. Fonseca CT, Cunha-Neto E, Kalil J, Jesus AR, Correa-Oliveira R, et al. (2004) Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells. Mem Inst Oswaldo Cruz 99: 63-66.
75. Fischer W PS, Theiler J, Bhattacharya T, Yusim K, et al (2006) Designing polyvalent HIV-1 vaccines for optimal coverage of potential T-cell epitopes in diverse global variants. Nat Med. In press.
76. Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, et al. (2003) IMGT/HLA and IMGT/MHC: Sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 31: 311-314.
77. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2006) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 34: D173-180.
78. Allcock RJ, Atrazhev AM, Beck S, de Jong PJ, Elliott JF, et al. (2002) The MHC haplotype project: A resource for HLA-linked association studies. Tissue Antigens 59: 520-521.
79. Traherne JA, Horton R, Roberts AN, Miretti MM, Hurles ME, et al. (2006) Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet 2: e9. DOI: 10.1371/journal.pgen.0020009
80. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, et al. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
81. Calef C, Thakalapally R, Lang D, Brander C, Goulder P, et al. (2000) PeptGen: Designing peptides for immunological studies and application to HIV consensus sequences. In: Korber BT, Brander C, Haynes B, Koup R, Moore JP, et al., editors. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory. pp. I-63.
82. McSparron H, Blythe MJ, Zygouri C, Doytchinova IA, Flower DR (2003) JenPep: A novel computational information resource for immunobiology and vaccinology. J Chem Inf Comput Sci 43: 1276-1287.
83. Blythe MJ, Flower DR (2005) Benchmarking B cell epitope prediction: Underperformance of existing methods. Protein Sci 14: 246-248.
84. Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47: 45-148.
85. Emini EA, Hughes JV, Perlow DS, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55: 836-839.
86. Karplus PA, Schulz GE (1985) Prediction of chain flexibility in proteins - A tool for the selection of peptide antigens. Naturwissenschafren 72: 212-213.
87. Parker JM, Guo D, Hodges RS (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25: 5425-5432.
88. Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276: 172-174.
89. Martin AC (1996) Accessing the Kabat antibody sequence database by computer. Proteins 25: 130-133.
90. Chen J, Anderson JB, DeWeese-Scott C, Fedorova ND, Geer LY, et al. (2003) MMDB: Entrez's 3D-structure database. Nucleic Acids Res 31: 474-477.
91. Allcorn LC, Martin AC (2002) SACS - Self-maintaining database of antibody crystal structure information. Bioinformatics 18: 175-181.
92. Lefranc MP (2004) IMGT-ONTOLOGY and IMGT databases, tools and Web resources for immunogenetics and immunoinformatics. Mol Immunol 40: 647-660.
93. Lefranc MP, Giudicelli V, Kaas Q, Duprat E, Jabado-Michaloud J, et al. (2005) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 33: D593-D597.
94. Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, et al. (2002) Development of a DNA-MVA/HIVA vaccine for Kenya. Vaccine 20: 1995-1998.
95. Doria-Rose NA, Learn GH, Rodrigo AG, Nickle DC, Li F, et al. (2005) Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope. J Virol 79: 11214-11224.
96. Gao F, Weaver EA, Lu Z, Li Y, Liao HX, et al. (2005) Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. J Virol 79: 1154-1163.
97. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, et al. (2002) Diversity considerations in HIV-1 vaccine selection. Science 296: 2354-2360.